Inside these posts: Ron Burkel

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.

 

Barnes & Noble changes poison pill plan

Bookseller Barnes & Noble Inc. appears to have bowed to shareholder pressure and is changing its shareholder rights plan to limit further stakes by Chairman Leonard Riggio and his family, the company said Wednesday.

Burkle to keep fighting Barnes & Noble poison pill

Billionaire investor Ron Burkle plans to appeal a Delaware court ruling that upheld a  “poison pill” put in place by bookseller Barnes & Noble Inc.

Burkle, Barnes & Noble’s second largest shareholder with 18.8 percent,  is locked in a proxy battle with the largest U.S. bookstore chain. He is seeking to install three directors, including himself, at the company’s annual meeting this month. Get the full story »

Barnes & Noble says Burkle not fit for board

Barnes & Noble Co. said activist investor Ronald Burkle was unqualified to be on its board and accused the billionaire of trying to take over the bookseller through a proxy battle without rewarding shareholders. Get the full story »

Burkle deal dead, Barnes & Noble girds for proxy fight

Barnes & Noble said it failed to reach a deal to end a rift with billionaire investor Ron Burkle, casting doubt on the bookstore chain’s ability to attract buyers and raising the specter of a proxy battle.

“Barnes & Noble and Yucaipa were unable to conclude an agreement on mutually acceptable terms,” the company said in a statement on Thursday, referring to Burkle’s investment firm. Get the full story »